Alectinib-responsive infantile anaplastic ganglioglioma with a novel VCL-ALK gene fusion

Pediatr Blood Cancer. 2021 Sep;68(9):e29122. doi: 10.1002/pbc.29122. Epub 2021 May 21.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anaplastic Lymphoma Kinase / genetics
  • Brain Neoplasms* / drug therapy
  • Brain Neoplasms* / genetics
  • Carbazoles / therapeutic use*
  • Ganglioglioma* / diagnostic imaging
  • Ganglioglioma* / drug therapy
  • Ganglioglioma* / genetics
  • Gene Fusion
  • Humans
  • Oncogene Proteins, Fusion
  • Piperidines / therapeutic use*
  • Protein Kinase Inhibitors / therapeutic use*
  • Vinculin / genetics

Substances

  • Carbazoles
  • Oncogene Proteins, Fusion
  • Piperidines
  • Protein Kinase Inhibitors
  • VCL protein, human
  • Vinculin
  • ALK protein, human
  • Anaplastic Lymphoma Kinase
  • alectinib